Search Results - "OBRYNBA, KATHRYN"
-
1
Review of Prader-Willi syndrome: the endocrine approach
Published in Translational pediatrics (01-10-2017)“…Prader-Willi syndrome (PWS) is a complex genetic disorder with implications on the endocrine and neurologic systems, metabolism, and behavior. Early in life,…”
Get full text
Journal Article -
2
Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial
Published in The journal of clinical endocrinology and metabolism (01-07-2023)“…Abstract Context Prader-Willi syndrome (PWS) is a rare neurobehavioral-metabolic disease caused by the lack of paternally expressed genes in the chromosome…”
Get full text
Journal Article -
3
Diazoxide choline extended‐release tablet in people with Prader‐Willi syndrome: results from long‐term open‐label study
Published in Obesity (Silver Spring, Md.) (01-02-2024)“…Objective This study assessed the effect of 1‐year administration of diazoxide choline extended‐release tablet (DCCR) on hyperphagia and other complications of…”
Get full text
Journal Article -
4
Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial
Published in The journal of clinical endocrinology and metabolism (01-07-2023)“…Abstract Context Prader-Willi syndrome (PWS) is a rare genetic disorder characterized by endocrine and neuropsychiatric problems including hyperphagia,…”
Get full text
Journal Article -
5
The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes
Published in Pediatric diabetes (01-03-2022)“…Objective The prevalence of depression among adolescents with type 1 diabetes is estimated to be 2–3 times higher than in the general population. In adults…”
Get full text
Journal Article -
6
No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test
Published in Journal of pediatric endocrinology & metabolism : JPEM (26-07-2018)“…Background Individuals with Prader-Willi syndrome (PWS) have hypothalamic dysfunction and may have central adrenal insufficiency (CAI). The prevalence of CAI…”
Get more information
Journal Article -
7
Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative
Published in Clinical diabetes (01-07-2021)“…Despite immense strides in therapeutic advances, clinical outcomes continue to be less than ideal for people with type 1 diabetes. This discrepancy has…”
Get full text
Journal Article -
8
The diabetes care index: A novel metric to assess delivery of optimal type 1 diabetes care
Published in Pediatric diabetes (01-06-2020)“…Objectives The American Diabetes Association (ADA) and the International Society for Pediatric and Adolescent Diabetes (ISPAD) have outlined standards for best…”
Get full text
Journal Article -
9
A Quality Improvement Project to Implement Choking Prevention and First Aid Education in Prader–Willi Syndrome Caregivers
Published in Journal of clinical medicine (27-10-2021)“…Prader–Willi syndrome (PWS) is a complex neurodevelopmental genetic disorder characterized by hypotonia and hyperphagia. Consequently, individuals with PWS are…”
Get full text
Journal Article -
10
The Type 1 Diabetes Composite Score: An Innovative Metric for Measuring Patient Care Outcomes Beyond Hemoglobin A1c
Published in Pediatric quality & safety (25-09-2020)“…INTRODUCTIONPatient outcomes resulting from optimal type 1 diabetes (T1D) care have historically focused on driving a single metric, hemoglobin A1c. Our…”
Get full text
Journal Article -
11
Update on Common Childhood Endocrine Disorders
Published in Current problems in pediatric and adolescent health care (01-09-2015)Get full text
Journal Article -
12
Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study
Published in Journal of diabetes science and technology (01-03-2023)“…Background: The benefits of Continuous Glucose Monitoring (CGM) on glycemic management have been demonstrated in numerous studies; however, widespread uptake…”
Get full text
Journal Article -
13
1042-P: Qualitative Study—Provider Awareness and Attitudes towards Type 1 Diabetes Antibody Screening
Published in Diabetes (New York, N.Y.) (20-06-2023)“…Background: This study explores awareness and attitudes of endocrinology providers toward type 1 diabetes (T1D) autoantibody screening and identifies perceived…”
Get full text
Journal Article -
14
1187-P: Patient Demographics and Clinical Outcomes among Type 1 Diabetes (T1D) Patients Using Continuous Glucose Monitors (CGMs): A Study from the Largest Cohort of T1D Patients in the U.S
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Background: CGM devices have been shown to improve glycemic control in patients with T1D. Despite existing clinical evidence and improved performance of CGM…”
Get full text
Journal Article -
15
823-P: Insulin Pump Use and Glycemic Control among Patients with Type 1 Diabetes: Trends from the T1DX-QI Cohort
Published in Diabetes (New York, N.Y.) (01-06-2021)Get full text
Journal Article -
16
Improving the Recognition and Management of Elevated Blood Pressure among Youth with Type 1 Diabetes
Published in Diabetes (New York, N.Y.) (01-07-2018)“…Background: Studies show that youth with type 1 diabetes (T1D) harbor cardiovascular risk factors and exhibit clinical signs suggestive of cardiovascular…”
Get full text
Journal Article -
17
Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes
Published in Clinical diabetes (01-07-2021)“…Continuous glucose monitoring (CGM) use is associated with improved A1C outcomes and quality of life in adolescents and young adults with diabetes; however,…”
Get full text
Journal Article -
18
145-LB: Improving Continuous Glucose Monitoring (CGM) Use across Ten National Centers: Results from the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Many studies have demonstrated the clinical benefit of continuous glucose monitoring (CGM) in type 1 diabetes (T1D). Although favorable insurance policy…”
Get full text
Journal Article -
19
1209-P: A Quality Improvement Initiative to Increase Utilization of Continuous Glucose Monitors Results in Improved Glycemic Outcomes in a Pediatric Diabetes Clinic
Published in Diabetes (New York, N.Y.) (01-06-2020)“…A minority of youth with type 1 diabetes (T1D) achieve HbA1c goals recommended by the ADA. Continuous glucose monitoring (CGM) is shown to improve glycemic…”
Get full text
Journal Article -
20
Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c
Published in Journal of pediatric endocrinology & metabolism : JPEM (26-01-2018)“…This study was designed to determine the effects of diabetes type and gender on depression risk determined by a highly sensitive screening questionnaire in…”
Get more information
Journal Article